Medications for Stelevation Myocardial Infarction

8 results

  • Clopidogrel (clopidogrel)

    (Clopidogrel)
    Wockhardt Limited
    Usage: Clopidogrel is indicated for patients with acute coronary syndrome (ACS) to reduce the risk of cardiovascular death, myocardial infarction (MI), or stroke. It is also used in individuals with recent MI, recent stroke, or established peripheral arterial disease to decrease the incidence of new ischemic events and vascular death.

  • Clopidogrel (clopidogrel)

    (Clopidogrel)
    Wockhardt USA LLC.
    Usage: Clopidogrel is indicated for reducing the risk of myocardial infarction and stroke in patients with acute coronary syndrome (including unstable angina and ST-elevation myocardial infarction) and those with a history of recent MI, stroke, or established peripheral arterial disease, in conjunction with aspirin.

  • Clopidogrel kit (clopidogrel kit)

    (Clopidogrel Kit)
    Cambridge Therapeutics Technologies, LLC
    Usage: Clopidogrel is indicated to reduce the risk of myocardial infarction and stroke in patients with acute coronary syndrome (ACS), including unstable angina and ST-elevation myocardial infarction, as well as in those with recent MI, recent stroke, or established peripheral arterial disease. It should be used with aspirin.

  • Enoxaparin sodium (enoxaparin sodium)

    (Enoxaparin sodium)
    BluePoint Laboratories
    Usage: Enoxaparin Sodium Injection is indicated for the prophylaxis of deep vein thrombosis (DVT) in surgical and medical patients, treatment of acute DVT with warfarin, prophylaxis of ischemic complications in unstable angina and myocardial infarction, and treatment of acute ST-segment elevation myocardial infarction (STEMI) with aspirin.

  • Enoxaparin sodium (enoxaparin sodium)

    (enoxaparin sodium)
    Fresenius Kabi USA, LLC
    Usage: Enoxaparin sodium is indicated for the prophylaxis of deep vein thrombosis (DVT) in at-risk patients, treatment of acute DVT with or without pulmonary embolism, prophylaxis of ischemic complications in unstable angina, and treatment of acute ST-segment elevation myocardial infarction (STEMI) alongside aspirin.

  • Prasugrel (prasugrel)

    (Prasugrel)
    Accord Healthcare Inc.
    Usage: Prasugrel is indicated for reducing thrombotic cardiovascular events in acute coronary syndrome patients undergoing percutaneous coronary intervention. This includes those with unstable angina, non-ST-elevation myocardial infarction, and ST-elevation myocardial infarction, showing efficacy in decreasing cardiovascular death and nonfatal myocardial infarction compared to clopidogrel.

  • Prasugrel (prasugrel)

    (Prasugrel)
    Golden State Medical Supply, Inc.
    Usage: Prasugrel tablets are indicated for reducing thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI), including those with unstable angina, non-ST-elevation myocardial infarction, and ST-elevation myocardial infarction managed with PCI.

  • Prasugrel (prasugrel)

    (Prasugrel)
    American Health Packaging
    Usage: Prasugrel tablets are indicated to reduce thrombotic cardiovascular events, including stent thrombosis, in patients with acute coronary syndrome undergoing percutaneous coronary intervention. This includes patients with unstable angina, non-ST-elevation myocardial infarction, and ST-elevation myocardial infarction.